HomeHYPMY • OTCMKTS
add
Hypera ADR
Previous close
$4.32
Day range
$4.15 - $4.27
Year range
$2.64 - $5.36
Market cap
14.51B BRL
Avg Volume
68.46K
P/E ratio
-
Dividend yield
-
Financials
Income Statement
Revenue
Net income
| (BRL) | Jun 2025info | Y/Y change |
|---|---|---|
Revenue | 2.15B | -1.60% |
Operating expense | 649.05M | 0.84% |
Net income | 426.69M | -13.42% |
Net profit margin | 19.81 | -11.99% |
Earnings per share | 0.68 | -12.82% |
EBITDA | 694.71M | -2.19% |
Effective tax rate | 1.82% | — |
Balance Sheet
Total assets
Total liabilities
| (BRL) | Jun 2025info | Y/Y change |
|---|---|---|
Cash and short-term investments | 1.20B | -57.56% |
Total assets | 24.24B | -4.47% |
Total liabilities | 12.24B | -8.25% |
Total equity | 11.99B | — |
Shares outstanding | 632.94M | — |
Price to book | 0.23 | — |
Return on assets | 6.65% | — |
Return on capital | 7.63% | — |
Cash Flow
Net change in cash
| (BRL) | Jun 2025info | Y/Y change |
|---|---|---|
Net income | 426.69M | -13.42% |
Cash from operations | 442.78M | -29.06% |
Cash from investing | -209.22M | -72.00% |
Cash from financing | -770.05M | 8.42% |
Net change in cash | -536.50M | -58.58% |
Free cash flow | -42.79M | -121.30% |
About
Hypera Pharma is a Brazilian multinational pharmaceutical
company and is the largest Brazilian pharmaceutical company by market capitalization. Headquartered in São Paulo, its business include pharmaceuticals, consumer healthcare and cosmetics products, and biotechnology products. Wikipedia
Founded
1999
Headquarters
Website
Employees
10,481
